Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial

Journal: Nature Communications

Published: 2020-06-23

DOI: 10.1038/s41467-020-16138-3

Affiliations: 20

Authors: 36

Go to article
Institutions Share
Leiden University Medical Center (LUMC), Netherlands 0.44
Deventer Hospital, Netherlands 0.11
Medisch Centrum Leeuwarden (MCL), Netherlands 0.06
Amphia Hospital, Netherlands 0.06
VieCuri Medical Center, Netherlands 0.06
Noordwest Hospital Group, Netherlands 0.06
Gelderse Vallei Hospital, Netherlands 0.06
HAGA Hospital, Netherlands 0.03
Dutch Breast Cancer Research Group, Netherlands 0.03
Alexander Monro Breast Cancer Hospital, Netherlands 0.03
Langeland Hospital, Netherlands 0.03
Isala Clinics, Netherlands 0.03
USC Longevity Institute (LI), United States of America (USA) 0.01
USC Department of Biological Sciences, United States of America (USA) 0.01
IFOM - FIRC Institute of Molecular Oncology, Italy 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER